Title | Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Oeltzschner G, S Wijtenburg A, Mikkelsen M, Edden RAE, Barker PB, Joo JHui, Leoutsakos J-MS, Rowland LM, Workman CI, Smith GS |
Journal | Neurobiol Aging |
Volume | 73 |
Pagination | 211-218 |
Date Published | 2019 Jan |
ISSN | 1558-1497 |
Keywords | Aged, Biomarkers, Cognition, Cognitive Dysfunction, Female, gamma-Aminobutyric Acid, Glutamates, Gyrus Cinguli, Humans, Magnetic Resonance Spectroscopy, Male, Middle Aged |
Abstract | The levels of several brain metabolites were investigated in the anterior cingulate cortex (ACC) and posterior cingulate cortex (PCC) in 13 healthy controls (HC) and 13 patients with mild cognitive impairment (MCI) using single-voxel magnetic resonance spectroscopy at 7T. Levels of γ-aminobutyric acid (GABA), glutamate (Glu), glutathione (GSH), N-acetylaspartylglutamate (NAAG), N-acetylaspartate (NAA), and myo-inositol (mI) were quantified relative to total creatine (tCr). The effect of diagnosis on metabolite levels, and relationships between metabolite levels and memory and executive function, correcting for age, were investigated. MCI patients showed significantly decreased GABA/tCr (ACC, PCC), Glu/tCr (PCC), and NAA/tCr (PCC), and significantly increased mI/tCr (ACC). In the combined group, worse episodic verbal memory performance was correlated with lower Glu/tCr (PCC), lower NAA/tCr (PCC), and higher mI/tCr (ACC, PCC). Worse verbal fluency performance was correlated with lower GSH/tCr (PCC). In summary, MCI is associated with decreased GABA and Glu, most consistently in the PCC. Further studies in larger patient samples should be undertaken to determine the utility of 7T magnetic resonance spectroscopy in detecting MCI-related neurochemical changes. |
DOI | 10.1016/j.neurobiolaging.2018.09.027 |
Alternate Journal | Neurobiol Aging |
PubMed ID | 30390554 |
PubMed Central ID | PMC6294473 |
Grant List | P30 AG066507 / AG / NIA NIH HHS / United States R01 AG041633 / AG / NIA NIH HHS / United States R01 AG038893 / AG / NIA NIH HHS / United States P41 EB015909 / EB / NIBIB NIH HHS / United States R21 MH098228 / MH / NIMH NIH HHS / United States R01 EB016089 / EB / NIBIB NIH HHS / United States UL1 TR001079 / TR / NCATS NIH HHS / United States P50 AG005146 / AG / NIA NIH HHS / United States K23 MH100705 / MH / NIMH NIH HHS / United States R01 EB023963 / EB / NIBIB NIH HHS / United States R01 MH106564 / MH / NIMH NIH HHS / United States R21 AG060245 / AG / NIA NIH HHS / United States |